In this review, we draw a picture on the current knowledge about the role of Notch3 in ovarian CSC behavior regulation, in order to suggest potential Notch3 inhibition-based cancer treatments aimed at improving the prognosis of OC patients. This evidence concerns the gene NOTCH3 and cancer.